General discussion, page-5140

FDA announcement is not as important as everyone thinks in my opinion. I think EUA is a long shot and we have to go through the trials process irrespective. For me the list of trial updates, Nasdaq listing and what that brings in US money and coverage are much more interesting. I think the market is starting to see that this is massively under valued compared to its US peers and with so many trials in large Medical areas this could be seriously very, very cheap here.

When we list on the Nasdaq and I say this as I am confident the BOD will get the job done, we enter a seriously big market that infants the Australian Market in so many ways. Brokers there need to accumulate tradeable stock from somewhere which dilutes what is available here on the open market. I think we will find this tightens up and moves extremely quickly on some announcements in OSA and Psychedelics.

Is it feasible that we are 1 billion MC on the back of a listing and some favourable updates..... absolutely in my eyes!